CA 19-9 is a glycoprotein as well as tumor marker, which is highly expressed in gastric, pancreatic and colonic adenocarcinomas as well as in salivary gland mucoepidermoid carcinomas and ovarian cancer. In general it is non-reactive with kidney, breast and prostate carcinomas.